Similarly, KIF23 mRNA levels were found to be higher in cancers, such as bladder, CNS tumors, breast, cervical, colorectal, esophageal, gastric, head and neck, liver, lung, lymphoma, melanoma, ovarian, pancreatic, and sarcoma compared to normal tissues, as depicted in Fig. (4B). Here, KIF23 is linked to sarcoma.